PD Dr. med. Dr. phil. Benjamin Kasenda

Erhart, C.-C., Cefalì, M., Mangan, D., Kasenda, B., & Wannesson, L. (2024). Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis [Journal-article]. Swiss Medical Weekly, 154(7), 3695. https://doi.org/10.57187/s.3695

Haug, N., Jänicke, M., Kasenda, B., Marschner, N., & Frank, M. (2024). Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients [Journal-article]. Quality of Life Research, 33(4), 1085–1094. https://doi.org/10.1007/s11136-023-03588-7

Schorb, Elisabeth, Isbell, Lisa Kristina, Kerkhoff, Andrea, Mathas, Stephan, Braulke, Friederike, Egerer, Gerlinde, Röth, Alexander, Schliffke, Simon, Borchmann, Peter, Brunnberg, Uta, Kroschinsky, Frank, Möhle, Robert, Rank, Andreas, Wellnitz, Dominique, Kasenda, Benjamin, Pospiech, Lisa, Wendler, Julia, Scherer, Florian, Deckert, Martina, et al. (2024). High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial. The Lancet Haematology, null. https://doi.org/10.1016/s2352-3026(23)00371-x

Hayoz S, Kasenda B, Schenker AL, Kopp C, Schär S, Thürlimann B, von Moos R, & Pless M. (2023). Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK). BMJ Open, 13(4), e068490. https://doi.org/10.1136/bmjopen-2022-068490

Hoang-Xuan K, Deckert M, Ferreri AJM, Furtner J, Gallego Perez-Larraya J, Henriksson R, Hottinger AF, Kasenda B, Lefranc F, Lossos A, McBain C, Preusser M, Roth P, Rudà R, Schlegel U, Soffietti R, Soussain C, Taphoorn MJB, Touitou V, et al. (2023). European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). Neuro-Oncology, 25(1), 37–53. https://doi.org/10.1093/neuonc/noac196

Finazzi, Tobias, Oliveira, Leonel, Mutz, Leonie, König, David, Kasenda, Benjamin, Lardinois Didier, Barbier, Michaela, Galactionova, Katya, Schwenkglenks, Matthias, Glinz, Dominik, Pletscher, Flurina, Rothschild, Sacha, & Rüter, Florian. (2023, January 1). Patient Reported Outcome Measures (PROMs) in a multidisciplinary lung cancer centre: a value-based healthcare pilot project. In SOCH. https://www.researchgate.net/publication/378675035_Patient_Reported_Outcome_Measures_PROMs_in_a_multidisciplinary_lung_cancer_centre_a_value-based_healthcare_pilot_project

Gloy, Viktoria, Schmitt, Andreas M., Düblin, Pascal, Hirt, Julian, Axfors, Cathrin, Kuk, Hanna, Pereira, Tiago V., Locher, Clara, Caquelin, Laura, Walter-Claudi, Martin, Lythgoe, Mark P., Herbrand, Amanda, Kasenda, Benjamin, & Hemkens, Lars G. (2023). The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020. International Journal of Cancer, 152, 2474–2484. https://doi.org/10.1002/ijc.34473

Martens, U. M., Schröder, J., Bengsch, F., Sellmann, L., Busies, S., Frank-Gleich, S., Zaiss, M., Decker, T., Schneeweiss, A., Schuler, M., Grebhardt, S., Zacharias, S., Marschner, N., Kasenda, B., Potthoff, K., & Vannier, C. (2023). The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice. BMC Cancer, 23. https://doi.org/10.1186/s12885-023-11046-3

Stanczak MA, Rodrigues Mantuano N, Kirchhammer N, Sanin DE, Jacob F, Coelho R, Everest-Dass AV, Wang J, Trefny MP, Monaco G, Bärenwaldt A, Gray MA, Petrone A, Kashyap AS, Glatz K, Kasenda B, Normington K, Broderick J, Peng L, et al. (2022). Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade. Science Translational Medicine, 14(669), eabj1270. https://doi.org/10.1126/scitranslmed.abj1270

Schmitt AM, Walter M, Herbrand AK, Jörger M, Moffa G, Novak U, Hemkens L, & Kasenda B. (2022). Characteristics and survival of patients with cancer with intended off-label use-a cohort study. BMJ Open, 12(5), e060453. https://doi.org/10.1136/bmjopen-2021-060453

Speich, Benjamin, Gryaznov, Dmitry, Busse, Jason W., Gloy, Viktoria L., Lohner, Szimonetta, Klatte, Katharina, Taji Heravi, Ala, Ghosh, Nilabh, Lee, Hopin, Mansouri, Anita, Marian, Ioana R., Saccilotto, Ramon, Nury, Edris, Kasenda, Benjamin, Ojeda–Ruiz, Elena, Schandelmaier, Stefan, Tomonaga, Yuki, Amstutz, Alain, Pauli–Magnus, Christiane, et al. (2022). Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis [Journal-article]. PLOS Medicine, 19(4), e1003980. https://doi.org/10.1371/journal.pmed.1003980

Gryaznov, D., von Niederhäusern, B., Speich, B., Kasenda, B., Ojeda-Ruiz, E., Blümle, A., Schandelmaier, S., Mertz, D., Odutayo, A., Tomonaga, Y., Amstutz, A., Pauli-Magnus, C., Gloy, V., Lohner, S., Bischoff, K., Wollmann, K., Rehner, L., Meerpohl, J. J., Nordmann, A., et al. (2022). Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE). BMJ Open, 12(5), e053417. https://doi.org/10.1136/bmjopen-2021-053417

Kasenda, B., König, D., Manni, M., Ritschard, R., Duthaler, U., Bartoszek, E., Bärenwaldt, A., Deuster, S., Hutter, G., Cordier, D., Mariani, L., Hench, J., Frank, S., Krähenbühl, S., Zippelius, A., Rochlitz, C., Mamot, C., Wicki, A., & Läubli, H. (2022). Targeting immunoliposomes to EGFR-positive glioblastoma. ESMO Open, 7. https://doi.org/10.1016/j.esmoop.2021.100365

Schmitt, Andreas Michael, Walter, Martin, Herbrand, Amanda Katherina, Jörger, Markus, Moffa, Giusi, Novak, Urban, Hemkens, Lars, & Kasenda, Benjamin. (2022). Characteristics and survival of patients with cancer with intended off-label use-a cohort study. BMJ Open, 12(5), e060453. https://doi.org/10.1136/bmjopen-2021-060453

Speich, B., Gryaznov, D., Busse, J. W., Gloy, V. L., Lohner, S., Klatte, K., Taji Heravi, A., Ghosh, N., Lee, H., Mansouri, A., Marian, I. R., Saccilotto, R., Nury, E., Kasenda, B., Ojeda-Ruiz, E., Schandelmaier, S., Tomonaga, Y., Amstutz, A., Pauli-Magnus, C., et al. (2022). Nonregistration, discontinuation, and nonpublication of randomized trials: a repeated metaresearch analysis. PLoS Med, 19(4), e1003980. https://doi.org/10.1371/journal.pmed.1003980

Taji Heravi A, Gryaznov D, Schandelmaier S, Kasenda B, Briel M, & Adherence to SPIRIT Recommendations (ASPIRE) Study Group. (2021). Evaluation of Planned Subgroup Analysis in Protocols of Randomized Clinical Trials. JAMA Network Open, 4(10), e2131503. https://doi.org/10.1001/jamanetworkopen.2021.31503

Herbrand, Amanda Katherina, Schmitt, Andreas M., Briel, Matthias, Ewald, Hannah, Goldkuhle, Marius, Diem, Stefan, Hoogkamer, Anouk, Joerger, Markus, Moffa, Giusi, Novak, Urban, Hemkens, Lars G., & Kasenda, Benjamin. (2021). Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. Jama Network Open, 4(3), e210380. https://doi.org/10.1001/jamanetworkopen.2021.0380

Lohner, Szimonetta, Gryaznov, Dmitry, von Niederhäusern, Belinda, Speich, Benjamin, Kasenda, Benjamin, Ojeda-Ruiz, Elena, Schandelmaier, Stefan, Mertz, Dominik, Odutayo, Ayodele, Tomonaga, Yuki, Amstutz, Alain, Pauli-Magnus, Christiane, Gloy, Viktoria, Bischoff, Karin, Wollmann, Katharina, Rehner, Laura, Meerpohl, Joerg J., Nordmann, Alain, Klatte, Katharina, et al. (2021). Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional study. Journal of Clinical Epidemiology, 139, 340–349. https://doi.org/10.1016/j.jclinepi.2021.05.011

Montesinos-Rongen M, Brunn A, Tuchscherer A, Borchmann P, Schorb E, Kasenda B, Altmüller J, Illerhaus G, Ruge MI, Maarouf M, Büttner R, Hansmann ML, Hallek M, Prinz M, Siebert R, & Deckert M. (2020). Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy. The Journal of Molecular Diagnostics : JMD, 22(10), 1300–1307. https://doi.org/10.1016/j.jmoldx.2020.07.002

Schorb E, Kasenda B, Ihorst G, Scherer F, Wendler J, Isbell L, Fricker H, Finke J, & Illerhaus G. (2020). High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study. Blood Advances, 4(14), 3378–3381. https://doi.org/10.1182/bloodadvances.2020002064

Schorb E, Fox CP, Kasenda B, Linton K, Martinez-Calle N, Calimeri T, Ninkovic S, Eyre TA, Cummin T, Smith J, Yallop D, De Marco B, Krampera M, Trefz S, Orsucci L, Fabbri A, Illerhaus G, Cwynarski K, & Ferreri AJM. (2020). Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice. British Journal of Haematology, 189(5), 879–887. https://doi.org/10.1111/bjh.16451

Gryaznov, D., Odutayo, A., von Niederhausern, B., Speich, B., Kasenda, B., Ojeda-Ruiz, E., Blumle, A., Schandelmaier, S., Mertz, D., Tomonaga, Y., Amstutz, A., Pauli-Magnus, C., Gloy, V., Bischoff, K., Wollmann, K., Rehner, L., Lohner, S., Meerpohl, J. J., Nordmann, A., et al. (2020). Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects. Trials, 21(1), 896. https://doi.org/10.1186/s13063-020-04808-y

Kasenda, Benjamin, Liu, Junhao, Jiang, Yu, Gajewski, Byron, Wu, Cen, von Elm, Erik, Schandelmaier, Stefan, Moffa, Giusi, Trelle, Sven, Schmitt, Andreas Michael, Herbrand, Amanda K., Gloy, Viktoria, Speich, Benjamin, Hopewell, Sally, Hemkens, Lars G., Sluka, Constantin, McGill, Kris, Meade, Maureen, Cook, Deborah, et al. (2020). Prediction of RECRUITment In Randomized Clinical Trials (RECRUIT-IT) - Rationale and Design for an International Collaborative Study. Trials, 21(1), 731. https://doi.org/10.1186/s13063-020-04666-8

Ladanie, Aviv, Schmitt, Andreas M., Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V., Sclafani, Francesco, Herbrand, Amanda K., Briel, Matthias, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P. A., Bucher, Heiner C., Kasenda, Benjamin, & Hemkens, Lars G. (2020). Clinical trial evidence supporting US Food and Drug Administration approval of novel cancer therapies between 2000 and 2016. Jama Network Open, 3(11), e2024406. https://doi.org/10.1001/jamanetworkopen.2020.24406

Schandelmaier, Stefan, Schmitt, Andreas M., Herbrand, Amanda K., Glinz, Dominik, Ewald, Hannah, Briel, Matthias, Guyatt, Gordon H., Hemkens, Lars G., & Kasenda, Benjamin. (2020). Characteristics and interpretation of subgroup analyses based on tumour characteristics in randomised trials testing target-specific anticancer drugs: design of a systematic survey. BMJ Open, 10(5), e034565. https://doi.org/10.1136/bmjopen-2019-034565

Schmitt AM, Herbrand AK, Fox CP, Bakunina K, Bromberg JEC, Cwynarski K, Doorduijn JK, Ferreri AJM, Illerhaus G, Issa S, Schorb E, Zucca E, Hemkens LG, Schandelmaier S, & Kasenda B. (2019). Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis. Hematological Oncology, 37(5), 548–557. https://doi.org/10.1002/hon.2666

Kashyap AS, Fernandez-Rodriguez L, Zhao Y, Monaco G, Trefny MP, Yoshida N, Martin K, Sharma A, Olieric N, Shah P, Stanczak M, Kirchhammer N, Park SM, Wieckowski S, Laubli, Heinz, Zagani R, Kasenda B, Steinmetz MO, Reinecker HC, & Zippelius A. (2019). GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses. Cell Reports, 28(13), 3367–3380. https://doi.org/10.1016/j.celrep.2019.08.057

Menter T, Ballova V., Caspar C., Wolff T., Kasenda B, Singer G., Juskevicius D., Tzankov A, & Dirnhofer S. (2019). ALK-negative anaplastic large cell lymphoma arising in the thrombus of an aortic prosthesis preceeded by clonally related lymphomatoid papulosis. Virchows Archiv : An International Journal of Pathology, 474(6), 763–767. https://doi.org/10.1007/s00428-019-02531-x

Schorb E, Finke J, Ihorst G, Kasenda B, Fricker H, & Illerhaus G. (2019). Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients. BMC cancer, 19(1), 287. https://doi.org/10.1186/s12885-019-5473-z

Martínez-Calle N, Hartley S, Ahearne M, Kasenda B, Beech A, Knight H, Balotis C, Kennedy B, Wagner S, Dyer MJS, Smith D, McMillan AK, Miall F, Bishton M, & Fox CP. (2019). Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis. British journal of haematology, 184(6), 957–968. https://doi.org/10.1111/bjh.15722

Helfenstein S, Riesterer O, Meier UR, Papachristofilou A, Kasenda B, Pless M, & Rothschild SI. (2019). 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis. Radiation Oncology (London, England), 14(1), 32. https://doi.org/10.1186/s13014-019-1235-y

Kasenda B, & Illerhaus G. (2019). CNS border posts against rituximab? The Lancet. Oncology, 20(2), 169–170. https://doi.org/10.1016/s1470-2045(18)30829-5

Herbrand, Amanda Katherina, Schmitt, Andreas Michael, Briel, Matthias, Diem, Stefan, Ewald, Hannah, Hoogkamer, Anouk, Joerger, Markus, Mc Cord, Kimberly Alba, Novak, Urban, Sricharoenchai, Sirintip, Hemkens, Lars G., & Kasenda, Benjamin. (2019). Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project. ESMO Open, 4(6), e000596. https://doi.org/10.1136/esmoopen-2019-000596

Ladanie, Aviv, Speich, Benjamin, Briel, Matthias, Sclafani, Francesco, Bucher, Heiner C., Agarwal, Arnav, Ioannidis, John P. A., Pereira, Tiago V., Kasenda, Benjamin, & Hemkens, Lars G. (2019). Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies. Journal of Clinical Epidemiology, 114, 49–59. https://doi.org/10.1016/j.jclinepi.2019.05.033

Speich, Benjamin, Schur, Nadine, Gryaznov, Dmitry, von Niederhäusern, Belinda, Hemkens, Lars G., Schandelmaier, Stefan, Amstutz, Alain, Kasenda, Benjamin, Pauli-Magnus, Christiane, Ojeda-Ruiz, Elena, Tomonaga, Yuki, McCord, Kimberly, Nordmann, Alain, von Elm, Erik, Briel, Matthias, Schwenkglenks, Matthias, & a collaboration of the Marta Aspire Study Groups. (2019). Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation. PLoS ONE, 14(1), e0210669. https://doi.org/10.1371/journal.pone.0210669

Trefny MP, Rothschild SI, Uhlenbrock F., Rieder, Dietmar, Kasenda, Benjamin, Stanczak, Michal A, Berner F, Kashyap AS, Kaiser M, Herzig, Petra, Poechtrager S, Thommen, Daniela S, Geier F., Savic S, Jermann P, Alborelli I., Schaub S., Stenner, Frank, Früh M, et al. (2019). A variant of a killer cell immunoglobulin-like receptor is associated with resistance to PD-1 blockade in lung cancer. Clinical Cancer Research, 25(10), 3026–3034. https://doi.org/10.1158/1078-0432.ccr-18-3041

Illerhaus G, Schorb E, & Kasenda B. (2018). Novel agents for primary central nervous system lymphoma: evidence and perspectives. Blood, 132(7), 681–688. https://doi.org/10.1182/blood-2018-01-791558

Briel M, Spoorenberg SMC, Snijders D, Torres A, Fernandez-Serrano S, Meduri GU, Gabarrús A, Blum CA, Confalonieri M, Kasenda B, Siemieniuk RAC, Boersma W, Bos WJW, Christ-Crain M, Ovidius Study Group, Capisce Study Group, & STEP Study Group. (2018). Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(3), 346–354. https://doi.org/10.1093/cid/cix801

Ladanie, Aviv, Ewald, Hannah, Kasenda, Benjamin, & Hemkens, Lars G. (2018). How to use FDA drug approval documents for evidence syntheses. BMJ, 362, k2815. https://doi.org/10.1136/bmj.k2815

Ladanie, Aviv, Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V., Sclafani, Francesco, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P. A., Bucher, Heiner C., Kasenda, Benjamin, & Hemkens, Lars G. (2018). The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: rationale and design of the database and the collection of evidence available at approval of novel drugs. Trials, 19(1), 505. https://doi.org/10.1186/s13063-018-2877-z

Speich, Benjamin, von Niederhäusern, Belinda, Blum, Claudine Angela, Keiser, Jennifer, Schur, Nadine, Fürst, Thomas, Kasenda, Benjamin, Christ-Crain, Mirjam, Hemkens, Lars G., Pauli-Magnus, Christiane, Schwenkglenks, Matthias, Briel, Matthias, & Making Randomized Trials Affordable Group. (2018). Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list. Journal of Clinical Epidemiology, 96, 73–83. https://doi.org/10.1016/j.jclinepi.2017.12.022

Speich, Benjamin, von Niederhäusern, Belinda, Schur, Nadine, Hemkens, Lars G., Fürst, Thomas, Bhatnagar, Neera, Alturki, Reem, Agarwal, Arnav, Kasenda, Benjamin, Pauli-Magnus, Christiane, Schwenkglenks, Matthias, Briel, Matthias, & Making Randomized Trials Affordable Group. (2018). Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data. Journal of Clinical Epidemiology, 96, 1–11. https://doi.org/10.1016/j.jclinepi.2017.12.018

Urech, Corinne, Grossert, Astrid, Alder, Judith, Scherer, Sandra, Handschin, Barbara, Kasenda, Benjamin, Borislavova, Borislava, Degen, Sven, Erb, Jennifer, Faessler, Alexandra, Gattlen, Laura, Schibli, Sarah, Werndli, Celine, Gaab, Jens, Berger, Thomas, Zumbrunn, Thomas, & Hess, Viviane. (2018). Web-Based Stress Management for Newly Diagnosed Patients With Cancer (STREAM): A Randomized, Wait-List Controlled Intervention Study. Journal of Clinical Oncology, 36(8), 780–788. https://doi.org/10.1200/jco.2017.74.8491

Kasenda B, Ihorst G, Schroers R, Korfel A, Schmidt-Wolf I, Egerer G, von Baumgarten L, Röth A, Bloehdorn J, Möhle R, Binder M, Keller U, Lamprecht M, Pfreundschuh M, Valk E, Fricker H, Schorb E, Fritsch K, Finke J, & Illerhaus G. (2017). High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group. Leukemia, 31(12), 2623–2629. https://doi.org/10.1038/leu.2017.170

Rothschild, S. I., Helfenstein, S., Riesterer, O., Meier, U. R., Papachristofilou, A., Kasenda, B., & Pless, M. (2017). 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck: A multicentre, retrospective analysis. ANNALS OF ONCOLOGY, 28.

Schorb E, Fox CP, Fritsch K, Isbell L, Neubauer A, Tzalavras A, Witherall R, Choquet S, Kuittinen O, De-Silva D, Cwynarski K, Houillier C, Hoang-Xuan K, Touitou V, Cassoux N, Marolleau JP, Tamburini J, Houot R, Delwail V, et al. (2017). High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study. Bone Marrow Transplantation, 52(8), 1113–1119. https://doi.org/10.1038/bmt.2017.23

Murad MH, Guyatt GH, Domecq JP, Vernooij RWM, Erwin PJ, Meerpohl JJ, Prutsky GJ, Akl EA, Mueller K, Bassler D, Schandelmaier S, Walter SD, Busse JW, Kasenda B, Pagano G, Pardo-Hernandez H, Montori VM, Wang Z, & Briel M. (2017). Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit. Journal of clinical epidemiology, 82, 12–19. https://doi.org/10.1016/j.jclinepi.2016.10.006

Fritsch, Kristina, Kasenda, Benjamin, Schorb, Elisabeth, Hau, Peter, Bloehdorn, Johannes, Möhle, R., Löw, S., Binder, Mascha, Atta, Johannes, Keller, Ulrich, Wolf, Hans-Heinrich, Krause, Stefan W., Hess, Georg, Naumann, R., Sasse, S., Hirt, Carsten, Lamprecht, M., Martens, Uwe, Morgner, A., et al. (2017). High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). Leukemia, 31(4), 846–852. https://doi.org/10.1038/leu.2016.334

Moschetta M, Uccello M, Kasenda B, Mak G, McClelland A, Boussios S, Forster M, & Arkenau HT. (2017). Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade. BioMed research international, 2017, 1506824. https://doi.org/10.1155/2017/1506824

Schandelmaier, Stefan, Tomonaga, Yuki, Bassler, Dirk, Meerpohl, Joerg J., von Elm, Erik, You, John J., Bluemle, Anette, Lamontagne, Francois, Saccilotto, Ramon, Amstutz, Alain, Bengough, Theresa, Stegert, Mihaela, Olu, Kelechi K., Tikkinen, Kari A. O., Neumann, Ignacio, Carrasco-Labra, Alonso, Faulhaber, Markus, Mulla, Sohail M., Mertz, Dominik, et al. (2017). Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study. The Journal of Pediatrics, 184, 209–214. https://doi.org/10.1016/j.jpeds.2017.01.071

Briel M, Olu KK, von Elm E, Kasenda B, Alturki R, Agarwal A, Bhatnagar N, & Schandelmaier S. (2016). A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable. Journal of Clinical Epidemiology, 80, 8–15. https://doi.org/10.1016/j.jclinepi.2016.07.016

Hemkens LG, Benchimol EI, Langan SM, Briel M, Kasenda B, Januel JM, Herrett E, & von Elm E. (2016). The reporting of studies using routinely collected health data was often insufficient. Journal of Clinical Epidemiology, 79, 104–111. https://doi.org/10.1016/j.jclinepi.2016.06.005

Blumle A., Schandelmaier S., Oeller P., Kasenda B., Briel M., von Elm E., Akl E.A., Amstutz A., Bassler D., Bengough T., Bucher H.C., Burnand B., Busse J.W., Carrasco-Labra A., Ebrahim S., Faulhaber M., Gloy V., Ferreira-Gonzalez I., Guyatt G.H., et al. (2016). Premature discontinuation of prospective clinical studies approved by a research ethics committee - A comparison of randomised and non-randomised studies. PLoS ONE, 11(10). https://doi.org/10.1371/journal.pone.0165605

Kasenda B, Sauerbrei W, Royston P, Mercat A, Slutsky AS, Cook D, Guyatt GH, Brochard L, Richard JC, Stewart TE, Meade M, & Briel M. (2016). Multivariable fractional polynomial interaction to investigate continuous effect modifiers in a meta-analysis on higher versus lower PEEP for patients with ARDS. BMJ open, 6(9), e011148. https://doi.org/10.1136/bmjopen-2016-011148

Kasenda B, Loeffler J, Illerhaus G, Ferreri AJ, Rubenstein J, & Batchelor TT. (2016). The role of whole brain radiation in primary CNS lymphoma. Blood, 128(1), 32–36. https://doi.org/10.1182/blood-2016-01-650101

Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, et al. (2016). Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS medicine, 13(6), e1002046. https://doi.org/10.1371/journal.pmed.1002046

Diem S, Kasenda B, Spain L, Martin-Liberal J, Marconcini R, Gore M, & Larkin J. (2016). Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma. British Journal of Cancer, 114(3), 256–261. https://doi.org/10.1038/bjc.2015.467

Illerhaus, Gerald, Kasenda, Benjamin, Ihorst, Gabriele, Egerer, Gerlinde, Lamprecht, Monika, Keller, Ulrich, Wolf, Hans-Heinrich, Hirt, Carsten, Stilgenbauer, Stephan, Binder, Mascha, Hau, Peter, Edinger, Matthias, Frickhofen, Norbert, Bentz, Martin, Möhle, Robert, Röth, Alexander, Pfreundschuh, Michael, von Baumgarten, Louisa, Deckert, Martina, et al. (2016). High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. The Lancet. Haematology, 3(8), e388–97. https://doi.org/10.1016/s2352-3026(16)30050-3

Kasenda, Benjamin, Bass, Annatina, Koeberle, Dieter, Pestalozzi, Bernhard, Borner, Markus, Herrmann, Richard, Jost, Lorenz, Lohri, Andreas, & Hess, Viviane. (2016). Conditional Survival in Patients with Advanced Pancreatic Cancer. JOURNAL OF THE PANCREAS, 17, 60–65.

Kasenda B, Kühnl A, & Chau I. (2016). Beginning of a novel frontier: T-cell-directed immune manipulation in lymphomas. Expert review of hematology, 9(2), 123–135. https://doi.org/10.1586/17474086.2016.1122513

Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, et al. (2016). Planning and reporting of quality-of-life outcomes in cancer trials. (Patent No. 1). 27(1), Article 1. https://doi.org/10.1093/annonc/mdv559

Schandelmaier S., Von Elm E., You J.J., Blumle A., Tomonaga Y., Lamontagne F., Saccilotto R., Amstutz A., Bengough T., Meerpohl J.J., Stegert M., Olu K.K., Tikkinen K.A.O., Neumann I., Carrasco-Labra A., Faulhaber M., Mulla S.M., Mertz D., Akl E.A., et al. (2016). Premature discontinuation of randomized trials in critical and emergency care: A retrospective cohort study. Critical Care Medicine, 44(1), 130–137. https://doi.org/10.1097/ccm.0000000000001369

Schorb, Elisabeth, Finke, Juergen, Ferreri, Andrés J. M., Ihorst, Gabriele, Mikesch, Kristina, Kasenda, Benjamin, Fritsch, Kristina, Fricker, Heidi, Burger, Elvira, Grishina, Olga, Valk, Elke, Zucca, Emanuele, & Illerhaus, Gerald. (2016). High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix). BMC Cancer, 16, 282. https://doi.org/10.1186/s12885-016-2311-4

Stegert, Mihaela, Kasenda, Benjamin, von Elm, Erik, You, John J., Blümle, Anette, Tomonaga, Yuki, Saccilotto, Ramon, Amstutz, Alain, Bengough, Theresa, Briel, Matthias, Disco study group, & Disco study group. (2016). An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules. Journal of Clinical Epidemiology, 69, 152–160. https://doi.org/10.1016/j.jclinepi.2015.05.023

Diem, Stefan, Kasenda, Benjamin, Martin-Liberal, Juan, Lee, Alexander, Chauhan, Dharmisha, Gore, Martin, & Larkin, James. (2015). Prognostic score for patients with advanced melanoma treated with ipilimumab. European Journal of Cancer, 51(18), 2785–2791. https://doi.org/10.1016/j.ejca.2015.09.007

Kasenda, Benjamin, Larkin, James, & Gore, Martin. (2015). Immunotherapies in Early and Advanced Renal Cell Cancer. Progress in Tumor Research, 42, 1–10. https://doi.org/10.1159/000436988

Kasenda, B., Ferreri, A. J. M., Marturano, E., Forst, D., Bromberg, J., Ghesquieres, H., Ferlay, C., Blay, J. Y., Hoang-Xuan, K., Pulczynski, E. J., Fosså, A., Okoshi, Y., Chiba, S., Fritsch, K., Omuro, A., O’Neill, B. P., Bairey, O., Schandelmaier, S., Gloy, V., et al. (2015). First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL) - a systematic review and individual patient data meta-analysis. Annals of Oncology, 26(7), 1305–1313. https://doi.org/10.1093/annonc/mdv076

Kasenda, B., Schorb, E., Fritsch, K., Finke, J., & Illerhaus, G. (2015). Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma - a long-term follow-up study. Annals of Oncology, 26(3), 608–611. https://doi.org/10.1093/annonc/mdv002

O’Neill, A., Mikesch, K., Fritsch, K., Kasenda, B., Banerjee, L., Burns, F., Zakout, G., Johnston, R., Illerhaus, G., & Cwynarski, K. (2015). Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT. Bone Marrow Transplantation, 50(7), 999–1000. https://doi.org/10.1038/bmt.2015.18

Rosenthal, Rachel, Kasenda, Benjamin, Dell-Kuster, Salome, von Elm, Erik, You, John, Blümle, Anette, Tomonaga, Yuki, Saccilotto, Ramon, Amstutz, Alain, Bengough, Theresa, Meerpohl, Joerg J., Stegert, Mihaela, Tikkinen, Kari A. O., Neumann, Ignacio, Carrasco-Labra, Alonso, Faulhaber, Markus, Mulla, Sohail, Mertz, Dominik, Akl, Elie A., et al. (2015). Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study. Annals of Surgery, 262(1), 68–73. https://doi.org/10.1097/sla.0000000000000810

Schandelmaier, S., Conen, K., von Elm, E., You, J. J., Blümle, A., Tomonaga, Y., Saccilotto, Basel Institute for Clinical Epidemiology, Biostatistics, University Hospital of Basel, Switzerland., Amstutz, A., Bengough, T., Meerpohl, J. J., Stegert, M., Olu, K. K., Tikkinen, K. A. O., Neumann, I., Carrasco-Labra, A., Faulhaber, M., Mulla, S. M., et al. (2015). Planning and reporting of quality-of-life outcomes in cancer trials. Annals of Oncology, 26(9), 1966–1973. https://doi.org/10.1093/annonc/mdv283

Kasenda, Benjamin, Bass, Annatina, Koeberle, Dieter, Pestalozzi, Bernhard, Borner, Markus, Herrmann, Richard, Jost, Lorenz, Lohri, Andreas, & Hess, Viviane. (2014). Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer, 14, 728. https://doi.org/10.1186/1471-2407-14-728

Kasenda, Benjamin, Sauerbrei, Willi, Royston, Patrick, & Briel, Matthias. (2014). Investigation of continuous effect modifiers in a meta-analysis on higher versus lower PEEP in patients requiring mechanical ventilation--protocol of the ICEM study. Systematic Reviews, 3, 46. https://doi.org/10.1186/2046-4053-3-46

Kasenda, Benjamin, Schandelmaier, Stefan, Sun, Xin, von Elm, Erik, You, John, Blümle, Anette, Tomonaga, Yuki, Saccilotto, Ramon, Amstutz, Alain, Bengough, Theresa, Meerpohl, Joerg J., Stegert, Mihaela, Olu, Kelechi K., Tikkinen, Kari A. O., Neumann, Ignacio, Carrasco-Labra, Alonso, Faulhaber, Markus, Mulla, Sohail M., Mertz, Dominik, et al. (2014). Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications. Bmj, 349, g4539. https://doi.org/10.1136/bmj.g4539

Kasenda, Benjamin, von Elm, Erik, You, John, Blümle, Anette, Tomonaga, Yuki, Saccilotto, Ramon, Amstutz, Alain, Bengough, Theresa, Meerpohl, Joerg J., Stegert, Mihaela, Tikkinen, Kari A. O., Neumann, Ignacio, Carrasco-Labra, Alonso, Faulhaber, Markus, Mulla, Sohail M., Mertz, Dominik, Akl, Elie A., Bassler, Dirk, Busse, Jason W., et al. (2014). Prevalence, characteristics, and publication of discontinued randomized trials. Journal of the American Medical Association, 311(10), 1045–1051. https://doi.org/10.1001/jama.2014.1361

Zacher, Jonas, Kasenda, Benjamin, Engert, Andreas, & Skoetz, Nicole. (2014). The role of additional radiotherapy for primary central nervous system lymphoma. Cochrane Database of Systematic Reviews, 6, CD009211. https://doi.org/10.1002/14651858.cd009211.pub2

Kasenda B, Raatz H, & Bucher HC. (2013). [Lung cancer screening - an overview about chances and risks]. Therapeutische Umschau. Revue therapeutique, 70(4), 237–43; discussion 244. https://doi.org/10.1024/0040-5930/a000395

Kasenda, Benjamin, Haug, Vanessa, Schorb, Elisabeth, Fritsch, Kristina, Finke, Jürgen, Mix, Michael, Hader, Claudia, Weber, Wolfgang A., Illerhaus, Gerald, & Meyer, Philipp T. (2013). 18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma. Journal of Nuclear Medicine, 54(2), 184–191. https://doi.org/10.2967/jnumed.112.108654

Kasenda, B., Raatz, H., & Bucher, H. C. (2013). Lung cancer screening - an overview about chances and risks. Therapeutische Umschau, 70(4), 237–43; discussion 244. https://doi.org/10.1024/0040-5930/a000395

Prutsky, Gabriela J., Domecq, Juan Pablo, Erwin, Patricia J., Briel, Matthias, Montori, Victor M., Akl, Elie A., Meerpohl, Joerg J., Bassler, Dirk, Schandelmaier, Stefan, Walter, Stephen D., Zhou, Qi, Coello, Pablo Alonso, Moja, Lorenzo, Walter, Martin, Thorlund, Kristian, Glasziou, Paul, Kunz, Regina, Ferreira-Gonzalez, Ignacio, Busse, Jason, et al. (2013). Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design. Trials, 14, 335. https://doi.org/10.1186/1745-6215-14-335

Schorb, Elisabeth, Kasenda, Benjamin, Atta, Johannes, Kaun, Stephan, Morgner, Anke, Hess, Georg, Elter, Thomas, von Bubnoff, Nikolas, Dreyling, Martin, Ringhoffer, Mark, Krause, Stefan W., Derigs, Günter, Klimm, Beate, Niemann, D., Fritsch, Kristina, Finke, Jürgen, & Illerhaus, Gerald. (2013). Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation. Haematologica, 98(5), 765–770. https://doi.org/10.3324/haematol.2012.076075

Kasenda B., Von Elm E.B., You J., Blumle A., Tomonaga Y., Saccilotto R., Amstutz A., Bengough T., Meerpohl J., Stegert M., Tikkinen K.A.O., Neumann I., Carrasco-Labra A., Faulhaber M., Mulla S., Mertz D., Akl E.A., Bassler D., Busse J.W., et al. (2012). Learning from failure - Rationale and design for a study about discontinuation of randomized trials (DISCO study). BMC Medical Research Methodology, 12. https://doi.org/10.1186/1471-2288-12-131

Kasenda, Benjamin, Rehberg, Marcel, Thürmann, Petra, Franzem, Melanie, Veelken, Hendrik, Fritsch, Kristina, Schorb, Elisabeth, Finke, Jürgen, Lebiedz, Dirk, & Illerhaus, Gerald. (2012). The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients. Annals of Hematology, 91(8), 1257–1264. https://doi.org/10.1007/s00277-012-1441-2

Kasenda, Benjamin, von Elm, Erik B., You, John, Blümle, Anette, Tomonaga, Yuki, Saccilotto, Ramon, Amstutz, Alain, Bengough, Theresa, Meerpohl, Jörg, Stegert, Mihaela, Tikkinen, Kari A. O., Neumann, Ignacio, Carrasco-Labra, Alonso, Faulhaber, Markus, Mulla, Sohail, Mertz, Dominik, Akl, Elie A., Bassler, Dirk, Busse, Jason W., et al. (2012). Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study). BMC Medical Research Methodology, 12, 131. https://doi.org/10.1186/1471-2288-12-131

Kasenda, B., Schorb, E., Fritsch, K., Finke, J., & Illerhaus, G. (2012). Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study. Annals of Oncology, 23(10), 2670–2675. https://doi.org/10.1093/annonc/mds059

Nordmann AJ, Ferreira-González I, Kasenda B, Saccilotto R, Bassler D, Bhatnagar N, & Briel M. (2012). Fibrates for primary prevention of cardiovascular disease events. The Cochrane Database of Systematic Reviews, 3. https://doi.org/10.1002/14651858.cd009753

Nordmann, Alain J., Ferreira-González, Ignacio, Kasenda, Benjamin, Saccilotto, Ramon, Bassler, Dirk, Bhatnagar, Neera, & Briel, Matthias. (2012). Fibrates for primary prevention of cardiovascular disease events. Cochrane Database of Systematic Reviews, 3, CD009753. https://doi.org/10.1002/14651858.cd009753.pub2

Nordmann, Alain J., Kasenda, Benjamin, & Briel, Matthias. (2012). Meta-analyses: what they can and cannot do. Swiss Medical Weekly, 142, w13518. https://doi.org/10.4414/smw.2012.13518

Fritsch, K., Kasenda, B., Hader, C., Nikkhah, G., Prinz, M., Haug, V., Haug, S., Ihorst, G., Finke, J., & Illerhaus, G. (2011). Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly. Annals of Oncology, 22(9), 2080–2085. https://doi.org/10.1093/annonc/mdq712

Kasenda, Benjamin, Rückert, Anja, Farthmann, Juliane, Schilling, Georgia, Schnerch, Dominik, Prömpeler, Heinrich, Wäsch, Ralph, & Engelhardt, Monika. (2011). Management of multiple myeloma in pregnancy: strategies for a rare challenge. Clinical Lymphoma, Myeloma & Leukemia, 11(2), 190–197. https://doi.org/10.1016/j.clml.2011.03.009

Kasenda, Benjamin, Schorb, Elisabeth, Fritsch, Kristina, Hader, Claudia, Finke, Jürgen, & Illerhaus, Gerald. (2011). Primary CNS lymphoma--radiation-free salvage therapy by second autologous stem cell transplantation. Biology of Blood and Marrow Transplantation, 17(2), 281–283. https://doi.org/10.1016/j.bbmt.2010.11.011

Kasenda B, Harter P, Hirsch T, Ast A, Buhrmann C, Glaser F, & Du Bois A. (2009). Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary. Acta obstetricia et gynecologica Scandinavica, 88(11), 1288–1290. https://doi.org/10.3109/00016340903242461

Kasenda B, Kassmer SH, Niggemann B, Schiermeier S, Hatzmann W, Zänker KS, & Dittmar T. (2008). The stromal cell-derived factor-1alpha dependent migration of human cord blood CD34 haematopoietic stem and progenitor cells switches from protein kinase C (PKC)-alpha dependence to PKC-alpha independence upon prolonged culture in the presence of Flt3-ligand and interleukin-6. British journal of haematology, 142(5), 831–835. https://doi.org/10.1111/j.1365-2141.2008.07256.x

Weidt C, Niggemann B, Kasenda B, Drell TL, Zänker KS, & Dittmar T. (2007). Stem cell migration: a quintessential stepping stone to successful therapy. Current Stem Cell Research & Therapy, 2(1), 89–103. https://doi.org/10.2174/157488807779317008

Weidt, Corinna, Niggemann, Bernd, Kasenda, Benjamin, Drell, Theodore L, Zänker, Kurt S, & Dittmar, Thomas. (2007). Stem cell migration: a quintessential stepping stone to successful therapy. Current Stem Cell Research & Therapy, 2(1), 89–103.